ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3,3,Coronary artery stenosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
3,4,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
4,1,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
5,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,5,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,3,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
7,1,Bone infarction,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
7,2,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
7,3,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
7,4,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
7,5,Therapeutic response delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
8,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
8,5,Headache,Headaches NEC,Headaches,Nerv,N
8,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
8,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Metastases to fallopian tube,Metastases to specified sites,Metastases,Neopl,N
9,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
9,3,Metastases to ovary,Metastases to specified sites,Metastases,Neopl,N
9,4,Metastases to stomach,Metastases to specified sites,Metastases,Neopl,N
9,5,Metastases to uterus,Metastases to specified sites,Metastases,Neopl,N
9,6,Uterine cancer,Uterine neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,Y
10,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
12,1,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
13,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
13,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
14,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
14,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
15,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
15,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
15,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
16,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
16,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
17,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
17,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
17,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
17,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
17,6,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
18,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
18,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
20,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
21,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
21,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
21,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
21,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
21,5,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
21,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
21,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
22,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
22,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
23,1,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
24,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
25,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
26,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
26,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
27,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
27,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
27,3,Impaired gastric emptying,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
27,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
28,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
28,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
28,3,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
28,4,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
29,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
29,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
30,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
31,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
31,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
32,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
33,1,Headache,Headaches NEC,Headaches,Nerv,N
34,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
34,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
36,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
37,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
37,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
38,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
38,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
38,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
38,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
38,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
38,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
40,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
41,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
42,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
43,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
44,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
45,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
47,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
48,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
48,2,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
48,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
48,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
49,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
49,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
50,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
50,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
51,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
51,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
52,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
52,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
52,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
52,4,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
52,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
52,6,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
52,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
52,8,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
52,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
53,1,Creatinine renal clearance increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
53,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
53,3,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
54,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
54,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
54,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
54,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
54,6,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
55,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
55,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
55,3,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
55,4,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
55,5,Ehlers-Danlos syndrome,Connective tissue disorders congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
55,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
55,7,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,8,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
56,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
57,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
57,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
57,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
58,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
58,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
58,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
58,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
59,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
60,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
61,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
61,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
61,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
62,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
62,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
62,3,Iron metabolism disorder,Iron metabolism disorders NEC,Iron and trace metal metabolism disorders,Metab,N
62,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
62,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
62,6,Serum ferritin decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
63,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
64,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
64,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
64,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
64,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
65,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
66,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
66,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
66,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
66,4,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
66,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
67,1,Coronary artery stenosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
67,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
67,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
67,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,5,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,6,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
67,7,Gene mutation identification test positive,Gene analyses,Cytogenetic investigations and genetic analyses,Inv,N
67,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
67,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
68,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
68,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
69,2,Liver function test decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
70,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
70,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
71,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
71,2,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
71,3,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
71,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
71,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
71,6,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
71,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
71,8,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
71,10,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
71,11,Headache,Headaches NEC,Headaches,Nerv,N
71,12,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
71,13,Migraine,Migraine headaches,Headaches,Nerv,N
71,14,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
71,15,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
71,16,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
72,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
73,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
73,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
73,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
73,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
74,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
75,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
75,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
76,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
77,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
77,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
77,3,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
77,4,Eyelid skin dryness,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
77,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
77,6,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
77,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
77,8,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
77,9,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
78,1,Blood pH increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
78,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
78,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
78,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
78,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
78,6,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
79,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
79,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
80,1,Arterial disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
80,2,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
80,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
81,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
81,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
81,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
81,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
81,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
82,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
83,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
83,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
83,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
83,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
83,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
83,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
84,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
84,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
85,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
85,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
85,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
86,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
87,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
87,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
87,3,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
87,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
87,5,Renal artery stenosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
87,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
88,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
88,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
88,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
88,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
88,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
89,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
89,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
89,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
89,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
89,5,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
89,6,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
90,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
90,2,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
90,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
91,1,Clonal evolution,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
91,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,3,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,4,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
91,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
92,1,Clonal evolution,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
92,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,3,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,4,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
92,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
93,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,2,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
94,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
94,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
94,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
95,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
96,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
96,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
97,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
97,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
97,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
97,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
99,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
99,2,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
99,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
99,4,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
99,5,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
100,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
102,1,Cardiac dysfunction,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
102,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
103,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
104,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
104,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
105,1,Cytogenetic abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
105,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
106,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
106,2,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
106,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
106,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
106,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
107,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
107,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
107,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
107,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
107,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
107,6,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
108,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
108,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
108,3,Headache,Headaches NEC,Headaches,Nerv,N
109,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
109,3,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
109,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
109,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
110,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
111,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
111,2,Gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
112,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
112,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
113,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
113,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
113,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
113,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
114,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
114,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
114,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
114,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
115,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
116,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
117,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
117,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
117,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
118,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
118,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
119,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
119,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
120,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
121,1,Gastrointestinal stoma output increased,Gastrointestinal function diagnostic procedures,Gastrointestinal investigations,Inv,N
121,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
121,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
122,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
122,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
123,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
123,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
123,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
124,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
125,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
125,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
125,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
125,4,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
125,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
125,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
126,1,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
127,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,2,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
127,3,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
127,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
128,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
129,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
130,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
131,1,Liver function test decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
131,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
132,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
133,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
133,2,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
133,3,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
134,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
136,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
136,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
136,3,Gluten sensitivity,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
136,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
137,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
137,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
137,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
138,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
139,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
139,2,Exposure via partner,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
140,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
141,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
142,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
143,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
143,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
143,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
144,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
145,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
145,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
145,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
146,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
147,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
148,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
149,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
149,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
150,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
150,2,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
150,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
150,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
150,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
150,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
150,7,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
150,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
150,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
150,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
